2017 Society of Surgical Oncology

Pancreatic Cancer

Hydroxychloroquine Boosts Antitumor Activity of Neoadjuvant Chemotherapy for Pancreatic Cancer

Adding hydroxychloroquine, an inhibitor of autophagy, to neoadjuvant chemotherapy for pancreatic cancer increases its efficacy and alters the tumor’s molecular profile in a way that may render the tum...

Survivorship
Colorectal Cancer

Expert Point of View: Patrick S. Sullivan, MD

”This was a great study and novel, asking what longer-term survivors with colon cancer are dying from—the toxicity of our treatment or population-risk illnesses?” commented session co-moderator, Patr...

Survivorship
Colorectal Cancer

Common Causes of Death Predominate Among Long-Term Colorectal Cancer Survivors

Patients with colorectal cancer who survive at least 5 years are increasingly likely to die from causes that are common in the general population, highlighting the importance of screening and lifestyl...

Breast Cancer

Expert Point of View: Kelly M. McMasters, MD, PhD

“More and more, we are finding that traditional anatomic TNM staging has significant limitations in predicting prognosis, especially in such cases where response to therapy is an important considerat...

Breast Cancer

Neo-Bioscore Improves Staging of Breast Cancer Treated With Neoadjuvant Chemotherapy

A new score that incorporates tumor biology and response outperforms conventional histopathologic criteria for the staging of breast cancer treated with neoadjuvant chemotherapy, finds a retrospectiv...

Gastrointestinal Cancer

Expert Point of View: Daniel G. Coit, MD

“While these results are clearly superior to historical controls, the study prompts a number of questions,” session moderator, ­Daniel G. Coit, MD, a surgical oncologist at Memorial Sloan Kettering C...

Gastrointestinal Cancer

Hyperthermic Intraperitoneal Chemoperfusion May Be Efficacious for Peritoneal Metastases

Hyperthermic intraperitoneal chemoperfusion is efficacious when used as part of multimodality therapy for low-volume peritoneal metastases of gastric cancer, suggests a prospective single-arm phase II...

Featured Lectures Presented at Society of Surgical Oncology

James Ewing Lecture: Jedd D. Wolchok, MD, PhD, presented the 2017 James Ewing Lecture on “Immunologic Checkpoint Blockade: Exploring Combinations and Mechanisms.” Dr. Wolchok is the Lloyd J. Old a...

Breast Cancer

Expert Point of View: Steven L. Chen, MD

“Dr. Neuman and colleagues point out that patients often will seek out information on their diagnosis preconsultation,” commented session co-moderator Steven L. Chen, MD, a surgical oncologist with Oa...

Breast Cancer

Decision Aid Improves Breast Cancer Patients’ Knowledge of Surgical Options

A Web-based decision aid that allows women with early breast cancer to easily compare surgical treatment options helps them make more informed decisions, suggests a randomized trial reported at the 20...

Colorectal Cancer

Expert Point of View: Kelly M. McMasters, MD, PhD

“Several gene-expression profiles have been evaluated to predict prognosis in colorectal cancer, but none have become widely accepted or U.S. Food and Drug Administration–approved. This has important...

Colorectal Cancer

Machine Learning Model Predicts Colorectal Cancer Recurrence

A machine learning model that uses a set or ensemble of algorithms has good accuracy for predicting colorectal cancer recurrence, investigators reported during a plenary session at the 2017 Society of...

pancreatic cancer

SSO 2017: Preclinical Trial Shows Intratumoral Vaccination Induces Antitumor Response in Pancreatic Cancer

Building on their previous research focusing on intratumoral vaccination for the most common form of pancreatic cancer, investigators from Rutgers Cancer Institute of New Jersey and Rutgers Robert Woo...

Advertisement

Advertisement



Advertisement